MedPath

Continued Early Intervention for Recent-onset Schizophrenia

Phase 3
Terminated
Conditions
Schizophrenia
Registration Number
NCT00184509
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study was to determine whether outreach integrated treatment of first episode schizophrenia was more effecive than standard outpatient treatment.

Detailed Description

Early intervention for schizophrenia has spawned considerable enthusiasm among clinicians without solid research evidence to suport its benefits and costs. The present study is a random-controlled study of integrated biomedical and psychosocial treatment on a population of recent-onset cases.

Comparison(s): 50 consecutive referrals with schizophrenic disorders of less than two years duration were allocated randomly to a comprehensive model of integrated treatment or standard care for two years. Main outcome measures was psychopathology, psychosocial functioning and hospital admissions.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • first-episode schizophrenia
Exclusion Criteria
  • acute psychosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Rehospitalizations and psychotic relapse at two years
Secondary Outcome Measures
NameTimeMethod
Psychopathology, psychosocial changes, functioning, antipsychotic medication

Trial Locations

Locations (1)

Norwegian University of Science and Technology

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath